Skip to main contentSkip to navigation
Sirius Investors

IVME Stock: In Veritas Medical Diagnostics, Inc. Stock Price, Analysis & Insights

Get live IVME stock price $0.00, comprehensive In Veritas Medical Diagnostics, Inc. stock analysis, charts, news, and expert forecast. Real-time IVME stock data and investment insights.

0.00
99.77%Today
IVMEIn Veritas Medical Diagnostics, Inc. • Other OTC • Financial Services
Market Cap
60.23K
Volume
5.29K
52W High
0.30
52W Low
0.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its development phase, dedicated to researching and creating advanced medical devices for point-of-care diagnostics. Their leading product is a prothrombin monitor, which assesses ...

Company Information

CEO
G. T. Cooper
Sector
Financial Services
Industry
Shell Companies
Employees
7

Contact Information

Website
Address
The Green House
Country
GB

Investment Analysis & Business Insights

Financial Services
Shell Companies

Investment Highlights

Strong presence in the Financial Services sector with established market position

Higher growth potential with elevated volatility (Beta: 7.80)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for In Veritas Medical Diagnostics, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Financial Services may affect company performance
  • Past performance does not guarantee future results for In Veritas Medical Diagnostics, Inc.
  • Investors should consider how In Veritas Medical Diagnostics, Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

60.23K

P/E Ratio (TTM)

-0.00

Beta

7.80

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Financial Services Sector

The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.